IBD Patients With COVID-19 Not at Increased Risk of Severe Disease

NEW YORK (Reuters Health) - Patients with inflammatory bowel disease (IBD) who contract COVID-19 are not at increased risk of severe disease compared to people without IBD, new findings suggest.

While biologics and non-steroid immunomodulatory therapies were also not associated with worse COVID-19 outcomes in IBD patients, those who had received corticosteroids in the past three months were at greater risk of severe disease, Dr. Shailendra Singh of Charleston Gastroenterology in Charleston, West Virginia, and colleagues found...